Enterprise Value
$125.77 B
+$2.77 B+2.25%
7 min ago
Summary
- As of March 13, 2025, VRTX enterprise value is $125.77 billion, with a rise of +$2.77 billion (+2.25%) during the most recent trading day.
- Over the past year, VRTX enterprise value has increased by +$27.95 billion (+28.58%).
- VRTX enterprise value is now -0.72% below its all-time high of $126.68 billion.
Performance
VRTX Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
VRTX Enterprise Value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | +2.3% | +2.2% | +2.2% |
| 1 m1 month | +8.3% | +8.1% | +8.1% |
| 3 m3 months | +8.5% | +7.6% | +7.9% |
| 6 m6 months | +3.4% | +2.6% | +3.2% |
| ytdytd | +27.1% | +26.4% | +26.5% |
| 1 y1 year | +28.6% | +19.8% | +20.5% |
| 5 y5 years | +129.4% | +124.6% | +126.7% |
VRTX Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -0.7% | $113 B | +11.1% | |
| 3 m | 3-month | $127 B | -0.7% | $98 B | +28.5% |
| 6 m | 6-month | $127 B | -0.7% | $98 B | +28.5% |
| 1 y | 1-year | $127 B | -0.7% | $92 B | +36.1% |
| 3 y | 3-year | $127 B | -0.7% | $53 B | +135.7% |
| 5 y | 5-year | $127 B | -0.7% | $40 B | +214.8% |
| alltime | all time | $127 B | -0.7% | $60 M | >+9999.0% |
Vertex Pharmaceuticals Incorporated Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $125.77 B(+27.1%) |
| 2024 | $98.93 B(+53.1%) |
| 2022 | $64.62 B(+29.1%) |
| 2021 | $50.06 B(-11.2%) |
| 2020 | $56.37 B(+3.9%) |
| 2019 | $54.26 B(+34.9%) |
| 2018 | $40.22 B(+9.0%) |
| 2017 | $36.89 B(+105.5%) |
| 2016 | $17.95 B(-42.3%) |
| 2015 | $31.10 B(+7.5%) |
| 2014 | $28.92 B(+67.1%) |
| 2013 | $17.31 B(+85.9%) |
| 2012 | $9.31 B(+34.3%) |
| 2011 | $6.93 B(-6.6%) |
| 2010 | $7.42 B(-10.3%) |
| 2009 | $8.28 B(+85.1%) |
| 2008 | $4.47 B(+62.5%) |
| Date | Value |
|---|---|
| 2007 | $2.75 B(-40.6%) |
| 2006 | $4.63 B(+49.6%) |
| 2005 | $3.09 B(+173.0%) |
| 2004 | $1.13 B(+8.7%) |
| 2003 | $1.04 B(-27.1%) |
| 2002 | $1.43 B(-27.9%) |
| 2001 | $1.98 B(-53.6%) |
| 2000 | $4.28 B(+389.2%) |
| 1999 | $874.49 M(+18.2%) |
| 1998 | $740.03 M(-3.8%) |
| 1997 | $769.03 M(-6.5%) |
| 1996 | $822.75 M(+88.3%) |
| 1995 | $437.02 M(+126.9%) |
| 1994 | $192.63 M(-4.9%) |
| 1993 | $202.62 M(+80.6%) |
| 1992 | $112.20 M(-25.4%) |
| 1991 | $150.31 M |
FAQ
- What is Vertex Pharmaceuticals Incorporated enterprise value?
- What is the all time high enterprise value for Vertex Pharmaceuticals Incorporated?
- What is VRTX enterprise value year-to-date change?
- What is Vertex Pharmaceuticals Incorporated enterprise value year-on-year change?
What is Vertex Pharmaceuticals Incorporated enterprise value?
The current enterprise value of VRTX is $125.77 B
What is the all time high enterprise value for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high enterprise value is $126.68 B
What is VRTX enterprise value year-to-date change?
Vertex Pharmaceuticals Incorporated enterprise value has changed by +$26.85 B (+27.14%) since the beginning of the year
What is Vertex Pharmaceuticals Incorporated enterprise value year-on-year change?
Over the past year, VRTX enterprise value has changed by +$27.95 B (+28.58%)